Ltd (hereinafter referred to as “Atom Therapeutics”, formerly named as “Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.”) of class 1 innovative drug ABP-671 for the treatment of gout and ...
A study finds that close to three in 10 gout patients in Singapore have poor control of the disease. Gout is a painful condition affecting the joints. The study by SingHealth Polyclinics also finds ...
Ltd (hereinafter referred to as "Atom Therapeutics”, formerly named as "Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.”) of class 1 innovative drug ABP-671 for the treatment of gout and ...
Ltd.”) of class 1 innovative drug ABP-671 for the treatment of gout and hyperuricemia (the “Product”). In accordance with the Agreement, the Group is entitled to an exclusive ...